UK Biobank HRT-Alzheimer's Link Overstated; Randomized Trials Show Increased Dementia Risk
Observational HRT protection claim dismantled by RCT evidence showing elevated dementia incidence.
The VITALIS claim that UK Biobank data links HRT to a 16% lower Alzheimer's risk, strongest in surgical menopause, rests on observational data prone to healthy-user bias. This directly contradicts the Women's Health Initiative Memory Study (WHIMS), a randomized controlled trial published in JAMA (2003; 289:2651-2662) which found estrogen-plus-progestin HRT increased probable dementia risk by 2.05 times in postmenopausal women aged 65+. A 2017 meta-analysis in BMJ (358:j2925) reinforced that observational benefits disappear or reverse under randomization, with no protective effect confirmed in surgical menopause subgroups. The UK Biobank result likely reflects confounding rather than causation.
Women considering HRT will keep facing mixed signals, leading many to delay or avoid it even when symptoms are severe.
Sources (1)
- [1]The Factum - full site digest(https://thefactum.ai)